Urethane (Carbamic acid ethyl ester)
(Synonyms: 氨基甲酸乙酯; Ethyl carbamate; Carbamic acid ethyl ester; Ethylurethane) 目录号 : GC33902
Urethane (Carbamic acid ethyl ester)是一种具有酯类结构的有机化合物,可用于合成聚氨酯类材料,也曾作为通过静脉注射使用的麻醉剂。
Cas No.:51-79-6
Sample solution is provided at 25 µL, 10mM.
Urethane (Carbamic acid ethyl ester) is an organic compound with an ester structure, which can be used for the synthesis of polyurethane materials[1], and has also been used as an anesthetic for intravenous injection[2]. Urethane exerts its sedative, analgesic, and general anesthetic effects by inhibiting the transmission of nerve signals in the central nervous system, reducing the excitability of nerve cells[3]. However, Urethane has potential carcinogenicity, and long-term exposure or excessive intake can increase the risk of tumor occurrence in organs such as the liver and kidneys, and may also have adverse effects on the reproductive system[4].
In vitro, Urethane (10mM) perfused rat visual cortical neurons for 10min–2h, followed by depolarizing current stimulation for 1s, significantly inhibited action potential discharge and decreased membrane resistance[5]. Urethane (0.4%) treated normal mouse somatic cells (including fibroblasts and epithelial cells) and tumor cells (C57 sarcoma and adenocarcinoma 63 malignant cells) for 2 to 4 days, significantly inhibited the growth and mitosis of normal cells, reducing the mitosis rate by about 50%. However, Urethane significantly promoted the growth and mitosis of tumor cells, increasing the mitosis rate by 2 to 4 times[6].
In vivo, Urethane (1.25–1.5g/kg) was administered intraperitoneally to anesthetize 3–4-month-old Sprague-Dawley rats, significantly inducing glutamate overflow in different brain regions[7]. Urethane (1g/kg) was administered intraperitoneally to FVB, BALB/c, and C57B6 mice, with susceptible strains (FVB, BALB/c) showing early NF-κB activation and lung inflammation, while the resistant strain (C57B6) failed to activate NF-κB or induce lung inflammation[8].
References:
[1] Szelest-Lewandowska A, Masiulanis B, Szymonowicz M, et al. Modified polycarbonate urethane: synthesis, properties and biological investigation in vitro. J Biomed Mater Res A. 2007 Aug;82(2):509-20.
[2] Carter DA, Dyer RG. Inhibition by pentobarbitone and urethane of the in vitro response of the adenohypophysis to luteinising hormone-releasing hormone in male rats. Br J Pharmacol. 1979 Oct;67(2):277-81.
[3] Mondino A, González J, Li D, et al. Urethane anaesthesia exhibits neurophysiological correlates of unconsciousness and is distinct from sleep. Eur J Neurosci. 2024 Feb;59(4):483-501.
[4] Sotomayor RE, Collins TF. Mutagenicity, metabolism, and DNA interactions of urethane. Toxicol Ind Health. 1990 Jan;6(1):71-108.
[5] Sceniak MP, Maciver MB. Cellular actions of urethane on rat visual cortical neurons in vitro. J Neurophysiol. 2006 Jun;95(6):3865-74.
[6] LASNITZKI I. Some effects of urethane on the growth and mitosis of normal and malignant cells in vitro. Br J Cancer. 1949 Dec;3(4):501-9.
[7] Beitchman JA, Krishna G, Bromberg CE, et al. Effects of isoflurane and urethane anesthetics on glutamate neurotransmission in rat brain using in vivo amperometry. BMC Neurosci. 2023 Oct 10;24(1):52.
[8] Stathopoulos GT, Sherrill TP, Cheng DS, et al. Epithelial NF-kappaB activation promotes urethane-induced lung carcinogenesis. Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18514-9.
Urethane (Carbamic acid ethyl ester)是一种具有酯类结构的有机化合物,可用于合成聚氨酯类材料[1],也曾作为通过静脉注射使用的麻醉剂[2]。Urethane通过抑制中枢神经系统的神经信号传递,降低神经细胞兴奋性,从而发挥镇静、镇痛及全身麻醉效果[3]。但是Urethane具有潜在致癌性,长期接触或过量摄入会增加肝脏、肾脏等器官的肿瘤发生风险,且可能对生殖系统产生不良影响[4]。
在体外,Urethane(10mM)灌流大鼠视觉皮层神经元10min–2h,随后以去极化电流刺激1s,Urethane显著抑制动作电位放电,同时降低膜电阻[5]。Urethane(0.4%)处理小鼠正常体细胞(包括成纤维细胞和上皮细胞)和肿瘤细胞(C57肉瘤和腺癌63恶性细胞)2至4天,对正常细胞的生长和有丝分裂有显著抑制作用,有丝分裂率降低约50%,但对肿瘤细胞的生长和有丝分裂有显著促进作用,有丝分裂率增加2至4倍[6]。
在体内,Urethane(1.25–1.5g/kg)腹腔注射用于麻醉3–4月龄Sprague-Dawley大鼠,Urethane显著诱导了不同脑区的谷氨酸外溢[7]。Urethane(1g/kg)腹腔注射处理FVB、BALB/c和C57B6小鼠,易感品系(FVB、BALB/c)表现出早期NF-κB激活和肺部炎症,而耐受品系(C57B6)未激活NF-κB或诱导肺部炎症[8]。
Cell experiment [1]: | |
Cell lines | Mouse somatic cells (fibrocytes and epithelial cells), tumor cells (C57 sarcoma and adenocarcinoma 63 malignant cells) |
Preparation Method | Cells were cultured from mouse tissues using the hanging drop technique in a mixture of rat and fowl plasma and chick embryo extract. Urethane was added to the culture medium at a final concentration of 0.4%. |
Reaction Conditions | 0.4%; 2–4 days |
Applications | Urethane inhibited cell growth and mitosis in normal fibroblastic and epithelial cells, reducing mitosis to about half of the control value. In contrast, Urethane stimulated growth and mitosis in C57 sarcoma and adenocarcinoma 63 cells, increasing mitosis by 2 to 4 times compared to controls. |
Animal experiment [2]: | |
Animal models | FVB, BALB/c, and C57B6 mice |
Preparation Method | Mice were intraperitoneally injected with 1g/kg Urethane weekly for 4 weeks or a single injection with 4-month latency. Lung tissues were harvested for analysis of NF-κB activation, inflammation, and tumor formation. |
Dosage form | 1g/kg; i.p. |
Applications | Urethane induced NF-κB activation and inflammation in susceptible mouse strains (FVB, BALB/c), leading to increased lung tumor formation. Inhibition of NF-κB in airway epithelial cells reduced tumor formation. |
References: |
Cas No. | 51-79-6 | SDF | |
别名 | 氨基甲酸乙酯; Ethyl carbamate; Carbamic acid ethyl ester; Ethylurethane | ||
Canonical SMILES | NC(OCC)=O | ||
分子式 | C3H7NO2 | 分子量 | 89.09 |
溶解度 | DMSO : ≥ 125 mg/mL (1403.08 mM); H2O: ≥20mg/mL | 储存条件 | Store at RT |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 11.2246 mL | 56.123 mL | 112.246 mL |
5 mM | 2.2449 mL | 11.2246 mL | 22.4492 mL |
10 mM | 1.1225 mL | 5.6123 mL | 11.2246 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet